| TC | Stat | Stk | Ins | Fil | +d | +w | +m | +q | +h | +y | avg | 
|---|---|---|---|---|---|---|---|---|---|---|---|
| P | %ret | 1 | 1 | 1 | 2 | -1 | 3 | 20 | 1 | 22 | 8 | 
| P | %wins | 100 | 0 | 100 | 100 | 100 | 100 | 83 | 
| Filing Date | T Date | Ticker | Issuer | Inc | Sector | Ind | Industry | Owner | oSt | Rel | Title | T | TVal | Price | L | Qty | oc | Own | H | r2y | r1y | r6m | r3m | r6w | r3w | r7d | r3d | f1d | f1w | f1m | f3m | f6m | f1y | 
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 7/7/21 16:05 | 7/6/21 | PKI | Perkinelmer Inc | MA | Electr | LabEq | Laboratory Analytical Instrum | Gregoire Sylvie | MA | D | M.d | 231 | 46.27 | 0 | 5 | 40 | 17 | D | |||||||||||||||
| 7/7/21 16:05 | 7/6/21 | PKI | Perkinelmer Inc | MA | Electr | LabEq | Laboratory Analytical Instrum | Gregoire Sylvie | MA | D | S.d | -778 | 155.57 | 0 | -5 | -22 | 17 | D | |||||||||||||||
| 5/14/21 16:05 | 5/13/21 | PKI | Perkinelmer Inc | MA | Electr | LabEq | Laboratory Analytical Instrum | Gregoire Sylvie | MA | D | M.d | 231 | 46.27 | 0 | 5 | 40 | 17 | D | |||||||||||||||
| 5/14/21 16:05 | 5/13/21 | PKI | Perkinelmer Inc | MA | Electr | LabEq | Laboratory Analytical Instrum | Gregoire Sylvie | MA | D | S.d | -700 | 140.00 | 0 | -5 | -22 | 17 | D | |||||||||||||||
| 5/11/09 15:25 | 5/7/09 | CBST | Cubist Pharmaceuticals Inc | DE | Health | Drug | Pharmaceutical Preparations | Gregoire Sylvie | MA | D | P | 46 | 16.94 | 13 | 3 | 397 | 3 | D | -21 | -8 | -33 | -23 | 4 | -1 | 3 | 1 | 2 | -1 | 3 | 20 | 1 | 22 | 
| D | Derivative transaction in filing (usually option exercise) | 
| M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price | 
| A | Amended filing | 
| E | Error detected in filing | 
| S - Sale | Sale of securities on an exchange or to another person | 
| S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) | 
| F - Tax | Payment of exercise price or tax liability using portion of securities received from the company | 
| P - Purchase | Purchase of securities on an exchange or from another person |